A Big Study Found that Semaglutide Users Saw Increased Health Spending. Should We Be Surprised?

No Curve today, but if you’re really jonesing for something to read, this Politico Pro piece — about the under-appreciated reality that the savings from Medicare price controls won’t necessarily

CORRECTION: Last week, I flagged a study that looked at prices for generic drugs at a number of “direct to consumer” pharmacies. I noted that the researchers compared the prices

So to strip things down to the basics, most cost-effectiveness analyses of drugs look at only three components: 1) What does it cost? 2) How does it extend or improve